DJIA 17,086.63 0.00 0.00%
NASDAQ 4,473.70 0.00 0.00%
S&P 500 1,989.09 2.08 0.10%
market minute promo

24.14 0.00 (0.00%)

Quote as of


company name or ticker

Recent Quotes

OMED $24.14 0.00%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $22.05
Previous Close $24.14
Daily Range $21.76 - $24.48
52-Week Range $12.07 - $42.34
Market Cap $713.5M
P/E Ratio 3.98
Dividend (Yield) $0.00 (0.0%)
Volume 238,556
Average Daily Volume 184,446
Current FY EPS -$0.86

Sector

Industry

ONCOMED PHARMACEUTICALS INC (OMED) Description

ONCOMED PHARMACEUTICALS INC Website: http://www.oncomed.com/

News & Commentary

This Week in Biotech: Clinical Trials and Tribulations

The J.P. Morgan Healthcare Conference led to the release of five important clinical updates this week.

OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial Of Tarextumab (Anti-Not

OncoMed Pharmaceuticals Initiates Randomized Phase 2 "ALPINE" Clinical Trial Of Tarextumab (Anti-Notch 2/3, OMP-59R5) For Pancreatic Cancer

OncoMed's OMP-54F28 on Partial Clinical Hold - Analyst Blog

OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog

OncoMed's OMP-18R5 On Clinical Hold, Shares Down - Analyst Blog

OncoMed Pharmaceuticals (OMED) Falls: Stock Tumbles 8.8% - Tale of the Tape

Friday Sector Laggards: Biotechnology, Drugs

Celgene Earnings Grow Year Over Year in Q1 - Analyst Blog

Falling Earnings Estimates Signal Weakness Ahead for OncoMed Pharmaceuticals (OMED) - Tale of the Ta

Falling Earnings Estimates Signal Weakness Ahead for OncoMed Pharmaceuticals (OMED) - Tale of the Tape

OncoMed Presents Data on Multiple Anti-Cancer Stem Cell Programs at American Association for Cancer

OncoMed Presents Data on Multiple Anti-Cancer Stem Cell Programs at American Association for Cancer Research Annual Meeting

Celgene Extends Ties with Forma Therapeutics - Analyst Blog

OncoMed's Q4 Loss Narrows - Analyst Blog

See More OMED News...